About NZOZ Centrum Medyczne KERmed
Clinical Trials at NZOZ Centrum Medyczne KERmed
During the past decade, NZOZ Centrum Medyczne KERmed conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on
average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NZOZ Centrum Medyczne KERmed" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Bristol-Myers Squibb" with 3 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "AZTherapies, Inc."
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Centrum Medyczne KERmed"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at NZOZ Centrum Medyczne KERmed
According to Clinical.Site data, the most researched conditions in "NZOZ Centrum Medyczne KERmed" are
"Cardiovascular Disease" (3 trials), "Heart Failure" (3 trials), "Crohn's Disease" (2 trials), "Obesity" (2 trials) and "Overweight" (2 trials). Many other conditions were trialed in "NZOZ Centrum Medyczne KERmed" in a lesser frequency.
Clinical Trials Intervention Types at NZOZ Centrum Medyczne KERmed
Most popular intervention types in "NZOZ Centrum Medyczne KERmed" are "Drug" (18 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "BMS-986165" (2 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "ALZT-OP1a" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NZOZ Centrum Medyczne KERmed
The vast majority of trials in "NZOZ Centrum Medyczne KERmed" are
18 trials for "All" genders.
Clinical Trials Status at NZOZ Centrum Medyczne KERmed
Currently, there are NaN active trials in "NZOZ Centrum Medyczne KERmed".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in NZOZ Centrum Medyczne KERmed,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in NZOZ Centrum Medyczne KERmed, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".